PAP is a rare lung condition that can be difficult to diagnose because it may mimic many other more common lung diseases,” ...
New clinical-stage company will accelerate treatments for patients with ultra-rare diseases worldwide PHILADELPHIA, Oct. 7, 2025 /PRNewswire/ -- Gemma Biotherapeutics ("GEMMABio") – a leading global ...
Us Orphan Drug Rare Disease Market Offers US$ 190 Billion Opportunity Highlights Kuick ResearchDelhi, Oct. 31, 2025 (GLOBE ...